Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial".

Shao, Ruoyang; Liu, Chuan; Liu, Yanna; Mao, Hua; Li, Xun; Qi, Xiaolong

Shao, Ruoyang; Liu, Chuan; Liu, Yanna; Mao, Hua; Li, Xun; Qi, Xiaolong.

Afiliação

Shao R; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Liu C; Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu Y; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Mao H; Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Li X; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Qi X; Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Ann Surg ; 274(2): e194-e195, 2021 08 01.

Article em En | MEDLINE | ID: mdl-31714312

Assuntos

Hipertensão Portal; Somatostatina; Humanos; Pressão na Veia Porta; Transplantados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Somatostatina / Hipertensão Portal Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google